Skip to main content

COVID19

  • COVID-19

COVAX

  • COVAX

Country Hub

  • Country Portal

Secondary nav

  • Gavi COVAX AMC launch event
  • Ethics Hotline

Donate

  • Donate
  • EN
  • FR
Home

Main navigation

Menu
  • Our Alliance
    Our Alliance
    • About
    • Strategy
      • Phase 5 (2021-2025)
        • The equity goal
        • The healthy markets goal
        • The sustainability goal
        • The vaccine goal
      • Phase 4 (2016-2020)
        • The market shaping goal
        • The sustainability goal
        • The systems goal
        • The vaccine goal
      • Phase 3 (2011-2015)
        • The financing goal
        • The health systems goal
        • The market shaping goal
        • The vaccine goal
      • Phase 2 (2006-2010)
      • Phase 1 (2000-2005)
      • Risk management
      • Vaccine investment strategy
      • Gender and immunisation
    • Operating model
      • Gavi's partnership model
        • The Bill & Melinda Gates Foundation
        • UNICEF
        • WHO
        • The World Bank Group
        • Civil society organisations
        • Developing country governments
        • Developing country pharmaceutical industry
        • Industrialised country governments
        • Industralised country pharmaceutical industry
        • Research and technical institutes
      • Gavi's business model
      • Gavi Secretariat
      • Transparency and IATI
    • Governance
      • Gavi Board
        • Board Committees
        • Board composition
        • Board members
        • Board minutes
        • Calendar
      • Governance and legal structures
      • Corporate Policies
      • Audit and Investigations
    • Market Shaping
      • The Vaccine Innovation Prioritisation Strategy
      • Supply and procurement roadmaps
      • Product information for vaccines and cold chain equipment
      • Vaccine demand forecasting
    • Global Health & Development
      • Decade of vaccine collaboration
      • International Health Partnership for UHC 2030
      • Millennium Development Goals
      • Sustainable Development Goals
      • UN Global Strategy for Women's, Children's and Adolescents' Health
    • Work with us
      • Culture
      • Vacancies
      • Internship programme
      • RFPs and Consulting Opportunities

    @SaveTheChildren / Hanna Adcock

    #VaccinesWork  

    Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

    FOCUS AREAS Gavi@20 Progress report Partners Our Board


    CAREERS Current vacancies Internship programme RFPs and consulting


    Contact us Phishing and fraud

  • Programmes & Impact
    Programmes & Impact
    • How our support works
      • Support guidelines
        • Apply for vaccine support
        • Apply for health system strengthening support
        • Apply for cold chain equipment support
        • Report on and renew existing Gavi support
        • Access targeted country assistance
        • Additional support guidance documentation
      • Independent Review Committee
      • Joint appraisals
      • Grant performance frameworks
      • Country portal
    • Types of support
      • Vaccine support
        • Human papillomavirus
        • Inactivated polio vaccine
        • Japanese encephalitis
        • Measles and measles-rubella
        • Meningitis A
        • Oral cholera
        • Pentavalent
        • Pneumococcal
        • Rotavirus
        • Typhoid
        • Yellow fever
      • Health system and immunisation strengthening
        • Immunisation supply chain
        • Data
        • Leadership, management and coordination
        • Demand promotion
      • Partners' engagement framework
        • Targeted country assistance
        • Strategic focus areas
        • Foundational support
      • Making immunisation sustainable
        • Eligibility
        • Transitioning out of Gavi support
        • Co-financing
      • Civil society organisation
    • Country Hub
      • Africa
        • Angola
        • Benin
        • Burkina Faso
        • Burundi
        • Cameroon
        • Central African Republic (the)
        • Chad
        • Comoros
        • Congo
        • Congo, DR
        • Côte d’Ivoire
        • Eritrea
        • Ethiopia
        • Gambia
        • Ghana
        • Guinea
        • Guinea-Bissau
        • Kenya
        • Lesotho
        • Liberia
        • Madagascar
        • Malawi
        • Mali
        • Mauritania
        • Mozambique
        • Niger
        • Nigeria
        • Rwanda
        • Sao Tome and Principe
        • Senegal
        • Sierra Leone
        • South Sudan
        • Tanzania, UR
        • Togo
        • Uganda
        • Zambia
        • Zimbabwe
      • Americas
        • Cuba
        • Haiti
        • Honduras
        • Nicaragua
        • Bolivia
        • Guyana
      • Eastern Mediterranean
        • Afghanistan
        • Djibouti
        • Pakistan
        • Somalia
        • Sudan
        • Yemen
      • Europe
        • Albania
        • Armenia
        • Azerbaijan
        • Bosnia & Herzegovina
        • Georgia
        • Kyrgyzstan
        • Moldova
        • Tajikistan
        • Turkmenistan
        • Ukraine
        • Uzbekistan
      • Southeast Asia
        • Bangladesh
        • Bhutan
        • India
        • Indonesia
        • Korea, DPR
        • Myanmar
        • Nepal
        • Sri Lanka
        • Timor Leste
      • Western Pacific
        • Cambodia
        • China
        • Kiribati
        • Lao PDR
        • Mongolia
        • Papua New Guinea
        • Solomon islands
        • Vietnam
    • Our impact
      • Measuring our performance
        • 2011 - 2015 indicators
        • 2016 - 2020 indicators
      • Countries approved for support
      • Disbursements and Commitments
      • Evaluation studies
        • Accelerated Vaccine Introduction project review
        • ADIPs and Hib Initiative Evaluation
        • Baseline study for AMC
        • Co-financing, eligibility and transition policies evaluation 2019
        • Cold Chain Equipment Optimization Platform Evaluation
        • Co-financing Policy Evaluation
        • Evaluation of Gavi support to CSO 2012
        • Evaluation of Gavi support to CSO 2018
        • Evaluation of the drivers of urban immunisation in Uganda; Kampala case study (Phase 1)
        • Full country evaluations
        • Gavi first evaluation report
        • Gavi second evaluation report
        • Gavi support to Albania evaluation
        • Gavi support to Bosnia and Herzegovina evaluation
        • Gavi-Government of China Hepatitis B vaccination programme
        • Gender policy evaluation
        • Gender policy evaluation 2019
        • Health system strengthening evaluations
        • IFFIm evaluation
        • Immunisation services support evaluation
        • Injection safety support evaluation
        • Measles campaigns in Nigeria
        • Mid-Term Evaluation of MoU8
        • Other studies
        • Pneumococcal AMC outcomes and impact evaluation
        • Pneumococcal AMC process and design
        • Review of Gavi’s Performance-Based Funding component of its Health System Strengthening support
        • Review of IRCs
        • Technical assistance through the Partners Engagement Framework evaluation
        • Using Geospatial Technologies to improve immunisation coverage and equity
        • Using digital technologies for real-time supplementary monitoring of immunisation activity
      • Facts and figures
      • Progress reports
    • Programmatic Policies
      • Co-financing policy
      • Eligibility and transitioning
      • Fragility, emergencies and refugees policy
      • Gender policy
      • Health system and immunisation strengthening support framework
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency and accountability
      • Vaccine donation policy

    SUPPORTED COUNTRIESSupported countriesGavi supported a total of 73 countries in 2018
    Explore our Country Hub ->

    FOR COUNTRIES

    Apply for support

    Renew support

     

    OUR RESULTS

    Evaluation studies

    Facts and figures

    Progress reports

  • Investing in Gavi
    Investing in Gavi
    • Resource mobilisation process
      • Gavi COVAX AMC Investment Opportunity Launch Event
      • Global Vaccine Summit 2020
      • Gavi's Investment Opportunity launch meeting, 30 August 2019
      • Gavi Mid-Term Review, Abu Dhabi high level conference, 10-11 December 2018
      • Gavi pledging conference January 2015
      • Gavi replenishment launch meeting May 2014
      • Gavi Mid-Term Review meeting October 2013
      • Gavi pledging conference June 2011
      • Call for Action and Resources October 2010
      • Financing Country Demand March 2010
    • Funding
      • Overview 2000-2037
      • Current period 2016-2020
      • Donor profiles
        • Airtel Nigeria
        • Al Ansari Exchange
        • Alwaleed Philanthropies
        • Audacious Alliance
        • Australia
        • The Bill & Melinda Gates Foundation
        • Brazil
        • Burkina Faso
        • Cameroon
        • Canada
        • The Children’s Investment Fund Foundation (UK)
        • China
        • China Merchants Charitable Foundation
        • Colombia
        • Comic Relief
        • Denmark
        • ELMA Vaccines and Immunization Foundation
        • European Commission
        • Finland
        • France
        • Germany
        • Girl Effect
        • Greece
        • HH Sheikh Mohammed bin Zayed Al Nahyan
        • Iceland
        • India
        • International Federation of Pharmaceutical Wholesalers
        • Ireland
        • Italy
        • Japan
        • Kingdom of Bhutan
        • Kingdom of Saudi Arabia
        • KS Relief
        • "la Caixa" Banking Foundation
        • Laerdal
        • Lions Club International Foundation (LCIF)
        • LDS Charities
        • Luxembourg
        • Mastercard
        • Mauritius
        • The Netherlands
        • New Zealand
        • Niger
        • Norway
        • Orange
        • Other private donors
        • Portugal
        • Principality of Monaco
        • Reckitt Benckiser Group
        • Red Nose Day Fund
        • Reed Hastings and Patty Quillin
        • Republic of Korea
        • Rockefeller Foundation
        • Russian Federation
        • South Africa
        • Spain
        • State of Qatar
        • State of Kuwait
        • Sultanate of Oman
        • Sweden
        • Switzerland
        • TikTok
        • TransferWise
        • Uganda
        • Unilever
        • United Kingdom
        • United States of America
        • UPS
    • Partnering with business
      • Financial partnerships
      • Leveraged partnerships
      • Operational partnerships
      • Become a partner
    • Innovative financing
      • IFFIm
      • Pneumococcal AMC
        • About the pneumococcal AMC
        • How it works
        • Manufacturers
        • How countries can apply
        • Timeline
        • Independent Assessment Committee
        • AMC legal agreements
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    Gavi COVAX AMC Investment Opportunity

    KEY AREAS

    Donor profiles

    Matching Fund

    Pneumococcal AMC

  • #VaccinesWork
    #VaccinesWork
    • COVID-19
    • Country stories
    • Photo stories
    • Videos
    • Opinions
    • Value of vaccination
      • Added value
      • Cost-effective
      • Health equity
      • Tried and tested

    FEATURED STORY

    The next pandemic

     

  • News & Resources
    News & Resources
    • Media room
      • News releases
      • Media contacts
      • Leadership biographies
    • Audio-visual
      • Videos
      • Galleries
      • Infographics
      • Presentations
    • Publications
    • Document library
      • COVID-19 situation reports
      • Evaluations
      • IRC reports
      • Financial reports

    KEY PUBLICATION

    Gavi innovation catalogue

     

    PROGRESS REPORT

    Download the 2019 Gavi progress report

  • Gavi COVAX AMC Launch Event

  • EN
  • FR
  • Home
  • Governance
  • Gavi Board
  • Governance committee
  • Governance Committee minutes
Back to

Governance Committee minutes

The Governance Committee assists the Board in fulfilling its responsibilities relating to developing and implementing sound Governance policies and practices for Gavi

View the Governance Committee

The Governance Committee assists the Board in fulfilling its responsibilities relating to developing and implementing sound Governance policies and practices for Gavi

View the Governance Committee

Minutes

10 December 2020

Governance Committee Meeting, 10 December 2020, Final Minutes

Download

24 November 2020

Governance Committee Meeting, 24 November 2020, Final Minutes

Download

8 October 2020

Governance Committee Meeting, 8 October 2020, Final Minutes

Download

8 September 2020

Governance Committee Meeting, 8 September 2020, Final Minutes

Download

18 June 2020

Governance Committee Meeting, 18 June 2020, Final Minutes

Download

30 April 2020

Governance Committee minutes 30 April 2020

Download

17 March 2020

Governance Committee minutes 17 March 2020

Download

11 February 2020

Governance Committee minutes 11 February 2020

Download

3 December 2019

Governance Committee minutes 3 December 2019

Download

25 November 2019

Governance Committee minutes 25 November 2019

Download

1 October 2019

Governance Committee minutes 1 October 2019

Download

24 June 2019

Governance Committee minutes 24 June 2019

Download

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next ›
  • Last page Last »
Last updated: 30 Mar 2021

Subscribe to our newsletter

Home

Footer

  • Our Alliance
  • Programmes & impact
  • Investing in Gavi
  • #VaccinesWork
  • News & resources

Country Hub

  • Country Portal

Donate

  • Donate

Footer nav

  • Careers
  • Contact
  • Ethics hotline
  • IFFIm
  • Privacy Policy
  • Terms of use
  • Phishing and fraud

© Gavi 2020

  • Gavi Facebook
  • Gavi Twitter
  • Gavi LinkedIn

Our achievements are thanks to the support and expertise of our founding partners